Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Human CD83 Fc Chimera Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Supplier: R&D Systems™ 2044CD050
This item is not returnable.
View return policy
Description
The Recombinant Human CD83 Fc Chimera Protein is derived from Sf 21 (baculovirus). The Recombinant Human CD83 Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 40.7 kDa (monomer) | |
| 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. | |
| Spodoptera frugiperda,Sf 21 (baculovirus)-derived human CD83 protein, (N-terminus) Human CD83 (Thr20-Ala143) Accession &Num;Q01151 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| Yes |
| 9308 | |
| CD83 Fc Chimera | |
| 50μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title